LUND, Sweden, March 27, 2025 /PRNewswire/ — Immunovia AB (publ) (“Immunovia” or the “Company”) hereby announces that the exercise price for warrants series TO 3 (the “warrants”) has been determined to SEK 0.24. The exercise period for the warrants commences on 1 April 2025 and runs up to…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.